Biomea Fusion BMEA
NASDAQ BMEA
$1.76 +0.05 (+2.92%)
As of: Sep 22, 2026 · 11:19 AM EDT

Biomea Fusion (BMEA) Cash from Investing Activities (2020 - 2026)

Biomea Fusion's (BMEA) quarterly Cash from Investing Activities came in at $550000.0 in Q1 2026, up 770.73% quarter-over-quarter from -$82000.0 in Q4 2024.

Analysis

Biomea Fusion (BMEA) Cash from Investing Activities (2020 - 2026) Analysis & Trends

Biomea Fusion has disclosed Cash from Investing Activities across 6 years of filings, most recently posting $550000.0 for Q1 2026.

  • In Q1 2026, Cash from Investing Activities changed N/A year-over-year to $550000.0; the TTM figure through Jun 2026 stood at $550000.0 (up 305.22% YoY), while the FY2024 annual figure was -$362000.0, up 83.69% from the prior year.
  • Cash from Investing Activities came in at $550000.0 for Q1 2026 at Biomea Fusion, up from -$82000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $20.4 million in Q1 2022 to a low of -$1.8 million in Q1 2023.
  • Average Cash from Investing Activities over 4 years is $1.9 million, with a median of -$39000.0 recorded in 2023.
  • Year-over-year, Cash from Investing Activities jumped 984.56% in 2022 and slumped 925.0% in 2024.
  • Over 4 years, Cash from Investing Activities stood at -$701000.0 in 2022, then surged by 98.86% to -$8000.0 in 2023, then tumbled by 925.0% to -$82000.0 in 2024, then jumped by 770.73% to $550000.0 in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were $550000.0 in Q1 2026, -$82000.0 in Q4 2024, and -$186000.0 in Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn -1.11 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn -1.20 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn -5.60 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn -3.11 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn 2.11 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn -1.61 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn -424.26 Mn
8 Revolution Medicines 40.91 Bn 40.91 Bn - -1.66 Bn
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn -49.35 Mn
10 Biomea Fusion 132.65 Mn 132.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 550,000.00
Dec 31, 2024 -82,000.00
Sep 30, 2024 -186,000.00
Jun 30, 2024 -59,000.00
Mar 31, 2024 -35,000.00
Dec 31, 2023 -8,000.00
Sep 30, 2023 -39,000.00
Jun 30, 2023 -417,000.00
Mar 31, 2023 -1.76 Mn
Dec 31, 2022 -701,000.00
Sep 30, 2022 225,000.00
Jun 30, 2022 7.38 Mn
Mar 31, 2022 20.44 Mn
Dec 31, 2021 4.55 Mn
Sep 30, 2021 -75,000.00
Jun 30, 2021 680,000.00
Mar 31, 2021 -38.51 Mn
Dec 31, 2020 -39,000.00
API Access

Biomea Fusion Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=BMEA&period=max&api_key=YOUR_API_KEY